Evidence map›Paper›PMID 40272519›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2025

Reducing lead toxicity with advanced nanotechnology methods.

Alireza Ghassemi Toussi, Sadaf Sadat Rafati, Elham Einafshar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alireza Ghassemi ToussiMedical Toxicology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Sadaf Sadat RafatiMedical Toxicology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Elham EinafsharPharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran. E.Einafshar@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lead exposure remains a pressing global health concern, particularly due to its pervasive nature in our environment and the associated toxicological risks. This review article explores the multifaceted aspects of lead, including its physical and chemical properties, the epidemiological prevalence of lead poisoning, and the pathophysiological mechanisms underlying its toxicity. Clinical manifestations, particularly in occupational settings, highlight the significant health impacts on vulnerable populations. We will discuss current methodologies for the identification and detection of lead, emphasizing the importance of prevention and treatment strategies to mitigate exposure. Given the growing interest in sustainable remediation approaches, microbial remediation techniques are evaluated for their effectiveness in addressing lead contamination. Furthermore, this review underscores the potential of nanoparticles in modifying lead toxicity. Focusing on their role in both in vitro and in vivo conditions, we examine how nanoparticles can influence lead bioavailability and toxicity in various environments, including wastewater, soil, and plants. Our findings suggest that nanoparticles offer innovative solutions for reducing lead's harmful effects, thus providing a pathway for enhanced environmental and public health protection. This comprehensive review aims to inform researchers, healthcare professionals, and policymakers about the potential of cutting-edge nanotechnology methods in combating lead toxicity and improving health outcomes.

Indexed as

Environmental PollutantsLeadLead PoisoningNanoparticlesNanotechnologyAnimalsEnvironmental ExposureHumansEnvironmental PollutantsLeadEnvironmentalLeadNanotechnologyToxicity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.